This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...